Eladynos (abaloparatide)
- Region
- 🇪🇺 EU
- Active substance
- abaloparatide
- Company
- Radius Health Ireland Ltd
- Status
- Refused
- Therapeutic area
- Osteoporosis
- CHMP opinion
- Thu 26 Jul 2018
- Application
- EMEA/H/C/004157
- ATC
- H05AA
- Official record
- www.ema.europa.eu
Indication
Treatment of osteoporosis.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Eladynos Authorised · Theramex Ireland Limited
Follow Eladynos
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.